BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28502497)

  • 21. Polymorphism at the TRIB1 gene modulates plasma lipid levels: insight from the Spanish familial hypercholesterolemia cohort study.
    Garcia-Rios A; Perez-Martinez P; Mata P; Fuentes F; Lopez-Miranda J; Alonso R; Caballero J; Mata N; Perez-Jimenez F; Ordovas JM
    Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):957-63. PubMed ID: 20692138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
    JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between polymorphisms rs1333040 and rs7865618 of chromosome 9p21 and sporadic brain arteriovenous malformations.
    Sturiale CL; Fontanella MM; Gatto I; Puca A; Giarretta I; D'Arrigo S; Lofrese G; Rainero I; Gallone S; Pinessi L; Ducati A; Maira G; Pola R
    Cerebrovasc Dis; 2014; 37(4):290-5. PubMed ID: 24820060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study.
    Ye S; Willeit J; Kronenberg F; Xu Q; Kiechl S
    J Am Coll Cardiol; 2008 Jul; 52(5):378-84. PubMed ID: 18652946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia.
    Paquette M; Fantino M; Bernard S; Baass A
    Atherosclerosis; 2021 Jul; 329():9-13. PubMed ID: 34157652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia.
    Koeijvoets KC; van der Net JB; Dallinga-Thie GM; Steyerberg EW; Mensink RP; Kastelein JJ; Sijbrands EJ; Plat J
    Atherosclerosis; 2009 Jun; 204(2):453-8. PubMed ID: 18977479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients.
    Pérez de Isla L; Alonso R; Argüeso R; Muñiz-Grijalvo O; Álvarez-Baños P; Badimón L; Watts GF; Mata P;
    J Clin Lipidol; 2022; 16(5):733-736. PubMed ID: 35906178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence variants on chromosome 9p21 are associated with ischemic stroke and the lipids level in Chinese Han population.
    Bi J; Yang L; Liu D; Wu J; Tong X; Cen S; Zhou D; Zhang T; Yi L
    J Stroke Cerebrovasc Dis; 2015 Apr; 24(4):894-900. PubMed ID: 25724239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common genetic variants do not associate with CAD in familial hypercholesterolemia.
    van Iperen EP; Sivapalaratnam S; Boekholdt SM; Hovingh GK; Maiwald S; Tanck MW; Soranzo N; Stephens JC; Sambrook JG; Levi M; Ouwehand WH; Kastelein JJ; Trip MD; Zwinderman AH
    Eur J Hum Genet; 2014 Jun; 22(6):809-13. PubMed ID: 24219970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Association at the 9p21 Glaucoma Locus Contributes to Sex Bias in Normal-Tension Glaucoma.
    Ng SK; Burdon KP; Fitzgerald JT; Zhou T; Fogarty R; Souzeau E; Landers J; Mills RA; Casson RJ; Ridge B; Graham SL; Hewitt AW; Mackey DA; Healey PR; Wang JJ; Mitchell P; MacGregor S; Craig JE
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3416-21. PubMed ID: 27367510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia.
    Aledo R; Alonso R; Mata P; Llorente-Cortés V; Padró T; Badimon L
    Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):807-12. PubMed ID: 22819221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia.
    Paquette M; Fantino M; Bernard S; Baass A
    J Clin Lipidol; 2020; 14(5):660-666. PubMed ID: 32807694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan.
    Mabuchi H
    J Atheroscler Thromb; 2017 Mar; 24(3):189-207. PubMed ID: 28179607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial hypercholesterolemia: PCSK9 InsLEU genetic variant and prediabetes/diabetes risk.
    Saavedra YGL; Dufour R; Baass A
    J Clin Lipidol; 2015; 9(6):786-793.e1. PubMed ID: 26687699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the rs1333040 polymorphism on the chromosomal 9p21 locus and sporadic brain arteriovenous malformations.
    Sturiale CL; Gatto I; Puca A; D'Arrigo S; Giarretta I; Albanese A; Di Rocco C; Maira G; Pola R
    J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1059-62. PubMed ID: 23606732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between the rs5498 (A > G) and rs281432 (C > G) polymorphisms of the
    Wechjakwen N; Aroonnual A; Prangthip P; Soonthornworasiri N; Phienluphon PP; Lainampetch J; Kwanbunjan K
    PeerJ; 2022; 10():e12972. PubMed ID: 35282277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia.
    Paquette M; Bernard S; Baass A
    Atherosclerosis; 2021 Oct; 335():41-46. PubMed ID: 34547589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Familial hypercholesterolemia and plasma Lp(a) levels: 2 cardiovascular risk factors].
    Real JT; Romero G; Priego MA; Chaves FJ; Ascaso JF; Carmena R
    An Med Interna; 1999 Feb; 16(2):69-72. PubMed ID: 10192997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.